Genentech advanced the collaboration's first neuroscience target into a joint early discovery program, providing early evidence that Recursion's platform can generate novel, biologically validated tar ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on July 27, ...

A third option is suppression: the United States would forgo development of ASI and stop anyone else from building it on the basis that superintelligence is just too dangerous to be unleashed on the ...

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an ...

Jack Clark, Anthropic’s co-founder, left on paternity leave last November. When he returned in February, he was surprised to ...

The fatal shooting of a 26-year-old Colombian man by a United States Immigration and Customs Enforcement (ICE) agent in Maine has become the latest flashpoint in President Donald Trump’s aggressive ...

They say everything is bigger in Texas, and if you take into account all that the state has to offer, it's easy to see why the Lone Star State packs such a potent punch with travelers. Texas is filled ...

New York state captivates both domestic and international travelers with the most populated city in the United States, sprawling state parks and a few beach communities. Whether you want to visit New ...

A federal appeals court has handed President Donald Trump a significant legal victory, clearing the way—at least temporarily—for a controversial proposal that could reshape how mail-in ballots are ...